Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205916 · ClinicalTrials.gov registry record · Phase 4
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
A Phase 4 study of Patient Preference, sponsored by Ophthalmic Consultants of Long Island.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04205916: Recruiting Phase 4 study of Patient Preference, sponsored by Ophthalmic Consultants of Long Island.
NCT04205916 is a Phase 4 study of Patient Preference that is actively recruiting participants, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04205916, a Phase 4 study of Patient Preference, is actively recruiting participants, sponsored by Ophthalmic Consultants of Long Island.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
Primary Outcome
Patient preference for medication protocol between the two eyes as assessed by using a standard set of questions
Conditions Studied
Interventions
- DRUG Dexamethasone
- OTHER Standard of care surgery
Study Locations (1)
New York
- Ophthalmic Consultants of Long Island - Garden City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 4 |
What NCT04205916 shows while recruiting
NCT04205916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Patient Preference appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04205916 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04205916 about?
NCT04205916 is a clinical study titled "A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery". To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
What is the current status of trial NCT04205916?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2019-11-04. Estimated completion is 2020-12-01.
What conditions does trial NCT04205916 study?
This clinical trial studies the following conditions: Patient Preference.
What interventions are being tested in trial NCT04205916?
The interventions under investigation include: Dexamethasone (DRUG), Standard of care surgery (OTHER).
Who is sponsoring clinical trial NCT04205916?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04205916 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Preference
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04205916's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI